- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.
According to our latest study, the global Oral Proteins and Peptides market size was valued at USD 2576 million in 2022 and is forecast to a readjusted size of USD 6614.7 million by 2029 with a CAGR of 14.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Ironwood & Allergan is one of the most important global manufacturers of oral proteins and peptides, other key manufacturers include Novo Nordisk. North America is the largest market, occupied for over 60%. In terms of type, insulin is the largest segment, with a share of over 60%. And in terms of application, gastric & digestive disorders and bone diseases segment holds the most share.
This report is a detailed and comprehensive analysis for global Oral Proteins and Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oral Proteins and Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Mg), 2018-2029
Global Oral Proteins and Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Mg), 2018-2029
Global Oral Proteins and Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Mg), 2018-2029
Global Oral Proteins and Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Mg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Proteins and Peptides
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Proteins and Peptides market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ironwood & Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, Novartis and Chiasma (Amryt Pharma). etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Oral Proteins and Peptides market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Market segment by Application
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Major players covered
Ironwood & Allergan
Novo Nordisk
Synergy Pharmaceuticals （Salix）
Novartis
Chiasma (Amryt Pharma)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Proteins and Peptides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Proteins and Peptides, with price, sales, revenue and global market share of Oral Proteins and Peptides from 2018 to 2023.
Chapter 3, the Oral Proteins and Peptides competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Proteins and Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oral Proteins and Peptides market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Proteins and Peptides.
Chapter 14 and 15, to describe Oral Proteins and Peptides sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Oral Proteins and Peptides
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oral Proteins and Peptides Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Linaclotide
1.3.3 Insulin
1.3.4 Plecanatide
1.3.5 Cyclosporine
1.3.6 Octreotide
1.4 Market Analysis by Application
1.4.1 Overview: Global Oral Proteins and Peptides Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Gastric & Digestive Disorders
1.4.3 Bone Diseases
1.4.4 Diabetes
1.4.5 Hormonal Disorders
1.5 Global Oral Proteins and Peptides Market Size & Forecast
1.5.1 Global Oral Proteins and Peptides Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oral Proteins and Peptides Sales Quantity (2018-2029)
1.5.3 Global Oral Proteins and Peptides Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Ironwood & Allergan
2.1.1 Ironwood & Allergan Details
2.1.2 Ironwood & Allergan Major Business
2.1.3 Ironwood & Allergan Oral Proteins and Peptides Product and Services
2.1.4 Ironwood & Allergan Oral Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Ironwood & Allergan Recent Developments/Updates
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business
2.2.3 Novo Nordisk Oral Proteins and Peptides Product and Services
2.2.4 Novo Nordisk Oral Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novo Nordisk Recent Developments/Updates
2.3 Synergy Pharmaceuticals （Salix）
2.3.1 Synergy Pharmaceuticals （Salix） Details
2.3.2 Synergy Pharmaceuticals （Salix） Major Business
2.3.3 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product and Services
2.3.4 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Synergy Pharmaceuticals （Salix） Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Oral Proteins and Peptides Product and Services
2.4.4 Novartis Oral Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments/Updates
2.5 Chiasma (Amryt Pharma)
2.5.1 Chiasma (Amryt Pharma) Details
2.5.2 Chiasma (Amryt Pharma) Major Business
2.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product and Services
2.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Chiasma (Amryt Pharma) Recent Developments/Updates
3 Competitive Environment: Oral Proteins and Peptides by Manufacturer
3.1 Global Oral Proteins and Peptides Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oral Proteins and Peptides Revenue by Manufacturer (2018-2023)
3.3 Global Oral Proteins and Peptides Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oral Proteins and Peptides by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oral Proteins and Peptides Manufacturer Market Share in 2022
3.4.2 Top 6 Oral Proteins and Peptides Manufacturer Market Share in 2022
3.5 Oral Proteins and Peptides Market: Overall Company Footprint Analysis
3.5.1 Oral Proteins and Peptides Market: Region Footprint
3.5.2 Oral Proteins and Peptides Market: Company Product Type Footprint
3.5.3 Oral Proteins and Peptides Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oral Proteins and Peptides Market Size by Region
4.1.1 Global Oral Proteins and Peptides Sales Quantity by Region (2018-2029)
4.1.2 Global Oral Proteins and Peptides Consumption Value by Region (2018-2029)
4.1.3 Global Oral Proteins and Peptides Average Price by Region (2018-2029)
4.2 North America Oral Proteins and Peptides Consumption Value (2018-2029)
4.3 Europe Oral Proteins and Peptides Consumption Value (2018-2029)
4.4 Asia-Pacific Oral Proteins and Peptides Consumption Value (2018-2029)
4.5 South America Oral Proteins and Peptides Consumption Value (2018-2029)
4.6 Middle East and Africa Oral Proteins and Peptides Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Oral Proteins and Peptides Sales Quantity by Type (2018-2029)
5.2 Global Oral Proteins and Peptides Consumption Value by Type (2018-2029)
5.3 Global Oral Proteins and Peptides Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Oral Proteins and Peptides Sales Quantity by Application (2018-2029)
6.2 Global Oral Proteins and Peptides Consumption Value by Application (2018-2029)
6.3 Global Oral Proteins and Peptides Average Price by Application (2018-2029)
7 North America
7.1 North America Oral Proteins and Peptides Sales Quantity by Type (2018-2029)
7.2 North America Oral Proteins and Peptides Sales Quantity by Application (2018-2029)
7.3 North America Oral Proteins and Peptides Market Size by Country
7.3.1 North America Oral Proteins and Peptides Sales Quantity by Country (2018-2029)
7.3.2 North America Oral Proteins and Peptides Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Oral Proteins and Peptides Sales Quantity by Type (2018-2029)
8.2 Europe Oral Proteins and Peptides Sales Quantity by Application (2018-2029)
8.3 Europe Oral Proteins and Peptides Market Size by Country
8.3.1 Europe Oral Proteins and Peptides Sales Quantity by Country (2018-2029)
8.3.2 Europe Oral Proteins and Peptides Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Oral Proteins and Peptides Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oral Proteins and Peptides Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oral Proteins and Peptides Market Size by Region
9.3.1 Asia-Pacific Oral Proteins and Peptides Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oral Proteins and Peptides Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Oral Proteins and Peptides Sales Quantity by Type (2018-2029)
10.2 South America Oral Proteins and Peptides Sales Quantity by Application (2018-2029)
10.3 South America Oral Proteins and Peptides Market Size by Country
10.3.1 South America Oral Proteins and Peptides Sales Quantity by Country (2018-2029)
10.3.2 South America Oral Proteins and Peptides Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Oral Proteins and Peptides Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oral Proteins and Peptides Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oral Proteins and Peptides Market Size by Country
11.3.1 Middle East & Africa Oral Proteins and Peptides Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oral Proteins and Peptides Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Oral Proteins and Peptides Market Drivers
12.2 Oral Proteins and Peptides Market Restraints
12.3 Oral Proteins and Peptides Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Oral Proteins and Peptides and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral Proteins and Peptides
13.3 Oral Proteins and Peptides Production Process
13.4 Oral Proteins and Peptides Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral Proteins and Peptides Typical Distributors
14.3 Oral Proteins and Peptides Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Oral Proteins and Peptides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oral Proteins and Peptides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Ironwood & Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Ironwood & Allergan Major Business
Table 5. Ironwood & Allergan Oral Proteins and Peptides Product and Services
Table 6. Ironwood & Allergan Oral Proteins and Peptides Sales Quantity (Kg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Ironwood & Allergan Recent Developments/Updates
Table 8. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 9. Novo Nordisk Major Business
Table 10. Novo Nordisk Oral Proteins and Peptides Product and Services
Table 11. Novo Nordisk Oral Proteins and Peptides Sales Quantity (Kg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Novo Nordisk Recent Developments/Updates
Table 13. Synergy Pharmaceuticals （Salix） Basic Information, Manufacturing Base and Competitors
Table 14. Synergy Pharmaceuticals （Salix） Major Business
Table 15. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product and Services
Table 16. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales Quantity (Kg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Synergy Pharmaceuticals （Salix） Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Oral Proteins and Peptides Product and Services
Table 21. Novartis Oral Proteins and Peptides Sales Quantity (Kg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novartis Recent Developments/Updates
Table 23. Chiasma (Amryt Pharma) Basic Information, Manufacturing Base and Competitors
Table 24. Chiasma (Amryt Pharma) Major Business
Table 25. Chiasma (Amryt Pharma) Oral Proteins and Peptides Product and Services
Table 26. Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales Quantity (Kg), Average Price (US$/Mg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Chiasma (Amryt Pharma) Recent Developments/Updates
Table 28. Global Oral Proteins and Peptides Sales Quantity by Manufacturer (2018-2023) & (Kg)
Table 29. Global Oral Proteins and Peptides Revenue by Manufacturer (2018-2023) & (USD Million)
Table 30. Global Oral Proteins and Peptides Average Price by Manufacturer (2018-2023) & (US$/Mg)
Table 31. Market Position of Manufacturers in Oral Proteins and Peptides, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 32. Head Office and Oral Proteins and Peptides Production Site of Key Manufacturer
Table 33. Oral Proteins and Peptides Market: Company Product Type Footprint
Table 34. Oral Proteins and Peptides Market: Company Product Application Footprint
Table 35. Oral Proteins and Peptides New Market Entrants and Barriers to Market Entry
Table 36. Oral Proteins and Peptides Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global Oral Proteins and Peptides Sales Quantity by Region (2018-2023) & (Kg)
Table 38. Global Oral Proteins and Peptides Sales Quantity by Region (2024-2029) & (Kg)
Table 39. Global Oral Proteins and Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 40. Global Oral Proteins and Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 41. Global Oral Proteins and Peptides Average Price by Region (2018-2023) & (US$/Mg)
Table 42. Global Oral Proteins and Peptides Average Price by Region (2024-2029) & (US$/Mg)
Table 43. Global Oral Proteins and Peptides Sales Quantity by Type (2018-2023) & (Kg)
Table 44. Global Oral Proteins and Peptides Sales Quantity by Type (2024-2029) & (Kg)
Table 45. Global Oral Proteins and Peptides Consumption Value by Type (2018-2023) & (USD Million)
Table 46. Global Oral Proteins and Peptides Consumption Value by Type (2024-2029) & (USD Million)
Table 47. Global Oral Proteins and Peptides Average Price by Type (2018-2023) & (US$/Mg)
Table 48. Global Oral Proteins and Peptides Average Price by Type (2024-2029) & (US$/Mg)
Table 49. Global Oral Proteins and Peptides Sales Quantity by Application (2018-2023) & (Kg)
Table 50. Global Oral Proteins and Peptides Sales Quantity by Application (2024-2029) & (Kg)
Table 51. Global Oral Proteins and Peptides Consumption Value by Application (2018-2023) & (USD Million)
Table 52. Global Oral Proteins and Peptides Consumption Value by Application (2024-2029) & (USD Million)
Table 53. Global Oral Proteins and Peptides Average Price by Application (2018-2023) & (US$/Mg)
Table 54. Global Oral Proteins and Peptides Average Price by Application (2024-2029) & (US$/Mg)
Table 55. North America Oral Proteins and Peptides Sales Quantity by Type (2018-2023) & (Kg)
Table 56. North America Oral Proteins and Peptides Sales Quantity by Type (2024-2029) & (Kg)
Table 57. North America Oral Proteins and Peptides Sales Quantity by Application (2018-2023) & (Kg)
Table 58. North America Oral Proteins and Peptides Sales Quantity by Application (2024-2029) & (Kg)
Table 59. North America Oral Proteins and Peptides Sales Quantity by Country (2018-2023) & (Kg)
Table 60. North America Oral Proteins and Peptides Sales Quantity by Country (2024-2029) & (Kg)
Table 61. North America Oral Proteins and Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 62. North America Oral Proteins and Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 63. Europe Oral Proteins and Peptides Sales Quantity by Type (2018-2023) & (Kg)
Table 64. Europe Oral Proteins and Peptides Sales Quantity by Type (2024-2029) & (Kg)
Table 65. Europe Oral Proteins and Peptides Sales Quantity by Application (2018-2023) & (Kg)
Table 66. Europe Oral Proteins and Peptides Sales Quantity by Application (2024-2029) & (Kg)
Table 67. Europe Oral Proteins and Peptides Sales Quantity by Country (2018-2023) & (Kg)
Table 68. Europe Oral Proteins and Peptides Sales Quantity by Country (2024-2029) & (Kg)
Table 69. Europe Oral Proteins and Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Oral Proteins and Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Oral Proteins and Peptides Sales Quantity by Type (2018-2023) & (Kg)
Table 72. Asia-Pacific Oral Proteins and Peptides Sales Quantity by Type (2024-2029) & (Kg)
Table 73. Asia-Pacific Oral Proteins and Peptides Sales Quantity by Application (2018-2023) & (Kg)
Table 74. Asia-Pacific Oral Proteins and Peptides Sales Quantity by Application (2024-2029) & (Kg)
Table 75. Asia-Pacific Oral Proteins and Peptides Sales Quantity by Region (2018-2023) & (Kg)
Table 76. Asia-Pacific Oral Proteins and Peptides Sales Quantity by Region (2024-2029) & (Kg)
Table 77. Asia-Pacific Oral Proteins and Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 78. Asia-Pacific Oral Proteins and Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 79. South America Oral Proteins and Peptides Sales Quantity by Type (2018-2023) & (Kg)
Table 80. South America Oral Proteins and Peptides Sales Quantity by Type (2024-2029) & (Kg)
Table 81. South America Oral Proteins and Peptides Sales Quantity by Application (2018-2023) & (Kg)
Table 82. South America Oral Proteins and Peptides Sales Quantity by Application (2024-2029) & (Kg)
Table 83. South America Oral Proteins and Peptides Sales Quantity by Country (2018-2023) & (Kg)
Table 84. South America Oral Proteins and Peptides Sales Quantity by Country (2024-2029) & (Kg)
Table 85. South America Oral Proteins and Peptides Consumption Value by Country (2018-2023) & (USD Million)
Table 86. South America Oral Proteins and Peptides Consumption Value by Country (2024-2029) & (USD Million)
Table 87. Middle East & Africa Oral Proteins and Peptides Sales Quantity by Type (2018-2023) & (Kg)
Table 88. Middle East & Africa Oral Proteins and Peptides Sales Quantity by Type (2024-2029) & (Kg)
Table 89. Middle East & Africa Oral Proteins and Peptides Sales Quantity by Application (2018-2023) & (Kg)
Table 90. Middle East & Africa Oral Proteins and Peptides Sales Quantity by Application (2024-2029) & (Kg)
Table 91. Middle East & Africa Oral Proteins and Peptides Sales Quantity by Region (2018-2023) & (Kg)
Table 92. Middle East & Africa Oral Proteins and Peptides Sales Quantity by Region (2024-2029) & (Kg)
Table 93. Middle East & Africa Oral Proteins and Peptides Consumption Value by Region (2018-2023) & (USD Million)
Table 94. Middle East & Africa Oral Proteins and Peptides Consumption Value by Region (2024-2029) & (USD Million)
Table 95. Oral Proteins and Peptides Raw Material
Table 96. Key Manufacturers of Oral Proteins and Peptides Raw Materials
Table 97. Oral Proteins and Peptides Typical Distributors
Table 98. Oral Proteins and Peptides Typical Customers
List of Figures
Figure 1. Oral Proteins and Peptides Picture
Figure 2. Global Oral Proteins and Peptides Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oral Proteins and Peptides Consumption Value Market Share by Type in 2022
Figure 4. Linaclotide Examples
Figure 5. Insulin Examples
Figure 6. Plecanatide Examples
Figure 7. Cyclosporine Examples
Figure 8. Octreotide Examples
Figure 9. Global Oral Proteins and Peptides Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Oral Proteins and Peptides Consumption Value Market Share by Application in 2022
Figure 11. Gastric & Digestive Disorders Examples
Figure 12. Bone Diseases Examples
Figure 13. Diabetes Examples
Figure 14. Hormonal Disorders Examples
Figure 15. Global Oral Proteins and Peptides Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Oral Proteins and Peptides Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Oral Proteins and Peptides Sales Quantity (2018-2029) & (Kg)
Figure 18. Global Oral Proteins and Peptides Average Price (2018-2029) & (US$/Mg)
Figure 19. Global Oral Proteins and Peptides Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Oral Proteins and Peptides Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Oral Proteins and Peptides by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Oral Proteins and Peptides Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Oral Proteins and Peptides Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Oral Proteins and Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Oral Proteins and Peptides Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Oral Proteins and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Oral Proteins and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Oral Proteins and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Oral Proteins and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Oral Proteins and Peptides Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Oral Proteins and Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Oral Proteins and Peptides Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Oral Proteins and Peptides Average Price by Type (2018-2029) & (US$/Mg)
Figure 34. Global Oral Proteins and Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Oral Proteins and Peptides Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Oral Proteins and Peptides Average Price by Application (2018-2029) & (US$/Mg)
Figure 37. North America Oral Proteins and Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Oral Proteins and Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Oral Proteins and Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Oral Proteins and Peptides Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Oral Proteins and Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Oral Proteins and Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Oral Proteins and Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Oral Proteins and Peptides Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Oral Proteins and Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Oral Proteins and Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Oral Proteins and Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Oral Proteins and Peptides Consumption Value Market Share by Region (2018-2029)
Figure 57. China Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Oral Proteins and Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Oral Proteins and Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Oral Proteins and Peptides Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Oral Proteins and Peptides Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Oral Proteins and Peptides Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Oral Proteins and Peptides Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Oral Proteins and Peptides Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Oral Proteins and Peptides Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Oral Proteins and Peptides Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Oral Proteins and Peptides Market Drivers
Figure 78. Oral Proteins and Peptides Market Restraints
Figure 79. Oral Proteins and Peptides Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Oral Proteins and Peptides in 2022
Figure 82. Manufacturing Process Analysis of Oral Proteins and Peptides
Figure 83. Oral Proteins and Peptides Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
